Source: CathWorks Blog

CathWorks Blog JIC 1: The New Era in Physiology is Here - CathWorks FFRangio System

The post JIC 1: The New Era in Physiology is Here - CathWorks FFRangio® System appeared first on CathWorks FFRangio System.

Read full article »

CathWorks's Competitors | CathWorks's News | CathWorks's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

100-250

President & CEO

Ramin Mousavi

CEO Approval Rating

84/100

CathWorks is an Israel-based medical technology company that designs, develops and distributes non-invasive diagnostic systems for the treatment of coronary artery disease.